Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Proceedings of the National Academy of Sciences of the United States of America
|
February 12, 2014
Resveratrol and aspirin eliminate tetraploid cells for anticancer chemoprevention
Delphine Lissa, Laura Senovilla, Santiago Rello-Varona, et al.
BMC Cancer
|
March 25, 2021
EML4-ALK induces cellular senescence in mortal normal human cells and promotes anchorage-independent growth in hTERT-transduced normal human cells
Akihiko Miyanaga, Masaru Matsumoto, Jessica A Beck, et al.
EMBO Molecular Medicine
|
March 23, 2012
Selective killing of p53-deficient cancer cells by SP600125
Mohamed Jemaà, Ilio Vitale, Oliver Kepp, et al.
Nature Communications
|
April 20, 2022
Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models
Delphine Lissa, Nobuyuki Takahashi, Parth Desai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2022
Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Charu Aggarwal, Nabil F Saba, Alain Algazi, et al.
Clinical Epigenetics
|
February 18, 2025
HOXA9 methylation is not associated with survival in Brazilian patients with lung adenocarcinoma
Anna Luiza Silva Almeida Vicente, Fabiana Aparecida de Souza Santos, Welinton Yoshio Hirai, et al.
The Lancet. Oncology
|
October 31, 2024
Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial
Mafalda Oliveira, Denys Pominchuk, Zbigniew Nowecki, et al.
Cancer Research
|
April 5, 2013
Cisplatin resistance associated with PARP hyperactivation
Judith Michels, Ilio Vitale, Lorenzo Galluzzi, et al.
Cell Reports. Medicine
|
June 19, 2024
Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities
Parth Desai, Nobuyuki Takahashi, Rajesh Kumar, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Proceedings of the National Academy of Sciences of the United States of America
|
February 12, 2014
Resveratrol and aspirin eliminate tetraploid cells for anticancer chemoprevention
Delphine Lissa, Laura Senovilla, Santiago Rello-Varona, et al.
BMC Cancer
|
March 25, 2021
EML4-ALK induces cellular senescence in mortal normal human cells and promotes anchorage-independent growth in hTERT-transduced normal human cells
Akihiko Miyanaga, Masaru Matsumoto, Jessica A Beck, et al.
EMBO Molecular Medicine
|
March 23, 2012
Selective killing of p53-deficient cancer cells by SP600125
Mohamed Jemaà, Ilio Vitale, Oliver Kepp, et al.
Nature Communications
|
April 20, 2022
Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models
Delphine Lissa, Nobuyuki Takahashi, Parth Desai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2022
Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Charu Aggarwal, Nabil F Saba, Alain Algazi, et al.
Clinical Epigenetics
|
February 18, 2025
HOXA9 methylation is not associated with survival in Brazilian patients with lung adenocarcinoma
Anna Luiza Silva Almeida Vicente, Fabiana Aparecida de Souza Santos, Welinton Yoshio Hirai, et al.
The Lancet. Oncology
|
October 31, 2024
Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial
Mafalda Oliveira, Denys Pominchuk, Zbigniew Nowecki, et al.
Cancer Research
|
April 5, 2013
Cisplatin resistance associated with PARP hyperactivation
Judith Michels, Ilio Vitale, Lorenzo Galluzzi, et al.
Cell Reports. Medicine
|
June 19, 2024
Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities
Parth Desai, Nobuyuki Takahashi, Rajesh Kumar, et al.
Page
of 3